Evidence map›Paper›PMID 27179822›Full record

ArticleDrug and alcohol dependence2016

Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.

Helena Hansen, Carole Siegel, Joseph Wanderling, Danae DiRocco

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed, 2 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 2 syntheses or guidelines pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Chronic pain among primary fentanyl users: The concept of self-medication.European journal of pain (London, England) · 2025
    Article
  18. Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Helena HansenDepartments of Psychiatry and Anthropology, New York University, 550 First Avenue 20N37, New York, NY, 10016, United States; Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, United States. Electronic address: helena.hansen@nyumc.org.
Carole SiegelDepartment of Psychiatry, New York University, United States.
Joseph WanderlingNathan Kline Institute for Psychiatric Research, United States.
Danae DiRoccoUniversity of Maryland, Department of Psychiatry, United States.
New York University · USNathan Kline Institute for Psychiatric Research · US

Funding

Mainstreaming Opioid Maintenance Treatment into General Medicine: Effects on AddiK01DA032674 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HANSEN, HELENA BJERRING · 2012 to 2016
$903k
NIDA NIH HHS K01 DA032674
6 · The paper itself

Abstract

backgroundGeographic and demographic variation in buprenorphine and methadone treatment use in U.S. cities has not been assessed. Identifying variance in opioid maintenance is essential to improving treatment access and equity. PURPOSE: To examine the differential uptake of buprenorphine treatment in comparison to methadone treatment between 2004 and 2013 in neighborhoods in New York City characterized by income, race and ethnicity.

methodsSocial area (SA) analysis of residential zip codes of methadone and buprenorphine patients in NYC, which aggregated zip codes into five social areas with similar percentages of residents below poverty, identifying as Black non-Hispanic and as Hispanic, to examine whether treatment rates differed significantly among social areas over time. For each rate, mixed model analyses of variance were run with fixed effects for social area, year and the interaction of social area by year.

resultsBuprenorphine treatment increased in all social areas over time with a significantly higher rate of increase in the social area with the highest income and the lowest percentage of Black, Hispanic, and low-income residents. Methadone treatment decreased slightly in all social areas until 2011 and then increased bringing rates back to 2004 levels. Treatment patterns varied by social area.

conclusionsBuprenorphine treatment rates are increasing in all social areas, with slower uptake in moderate income mixed ethnicity areas. Methadone rates have remained stable over time. Targeted investments to promote public sector buprenorphine prescription may be necessary to reduce disparities in buprenorphine treatment and to realize its potential as a public health measure.

Indexed as

Analgesics, OpioidBlack or African AmericanBuprenorphineEthnicityFemaleHispanic or LatinoHumansMaleMethadoneNew York CityOpioid-Related DisordersPovertyRacial GroupsResidence CharacteristicsAnalgesics, OpioidBuprenorphineMethadoneBuprenorphineMethadoneRacial disparitiesTreatment disparities

Identifiers

PMID27179822
PMCPMC5539992
OpenAlexW2345719282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.